BPMC Blueprint Medicines Corp
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include BLU-285, BLU 554, and BLU-667.
$46.76 -1.02 (-2.14%)
As of 01/30/2023 15:59:59 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Mid cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 04/30/2015
Outstanding shares: 59,830,611
Average volume: 509,700
Market cap: $2,856,911,675
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: BWY52P3
Valuation (See tab for details)
PE ratio: -4.40
PB ratio: 3.23
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%